Cargando…

The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type 1 diabetes patients

AIMS: To determine the effect of the use of intermittently scanned continuous glucose monitoring (isCGM) on acute diabetes-related complications in adult type 1 diabetes patients. METHODS: Six hundred and forty-two adult type 1 diabetes patients with isCGM were identified from electronic health reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mustonen, Jyrki, Rautiainen, Päivi, Lamidi, Marja-Leena, Lavikainen, Piia, Martikainen, Janne, Laatikainen, Tiina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198841/ https://www.ncbi.nlm.nih.gov/pubmed/36977968 http://dx.doi.org/10.1007/s00592-023-02079-y

Ejemplares similares

Marked Improvement in A1C Levels After Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Maintained Over 4 Years in Patients With Type 1 Diabetes
por: Mustonen, Jyrki, et al.
Publicado: (2022)

Effects of COVID-19 Pandemic and Lockdown on Monitoring and Treatment Balance of Finnish Coronary Heart Disease and Type 2 Diabetes Patients
por: Lavikainen, Piia, et al.
Publicado: (2022)

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2020)

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2022)

Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM
por: Hohendorff, Jerzy, et al.
Publicado: (2022)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

The effect of the integration of health services on health care usage among patients with type 2 diabetes in North Karelia, Finland
por: Wikström, Katja, et al.
Publicado: (2021)

Trends in the process and outcome indicators of type 2 diabetes care: a cohort study from Eastern Finland, 2012–2017
por: Lamidi, Marja-Leena, et al.
Publicado: (2020)

Mode of treatments and achievement of treatment targets among type 2 diabetes patients with different comorbidities – a register-based retrospective cohort study in Finland
por: Nazu, Nazma Akter, et al.
Publicado: (2022)

The Association of Personality Traits and Parameters of Glycemic Regulation in Type 1 Diabetes Mellitus Patients Using isCGM
por: Sladić Rimac, Daria, et al.
Publicado: (2022)

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
por: Jalkanen, Kari, et al.
Publicado: (2021)

Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland
por: Martikainen, Janne, et al.
Publicado: (2021)

Data-Driven Identification of Long-Term Glycemia Clusters and Their Individualized Predictors in Finnish Patients with Type 2 Diabetes
por: Lavikainen, Piia, et al.
Publicado: (2023)

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM
por: Kawaguchi, Yuji, et al.
Publicado: (2022)

The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland
por: Inglin, Laura, et al.
Publicado: (2022)

LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model
por: Inglin, Laura, et al.
Publicado: (2021)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

Factors affecting the effectiveness of the physical activity counselling intervention implemented in primary health care in adults with type 2 diabetes
por: Martiskainen, Tuula, et al.
Publicado: (2023)

Effectiveness of physical activity counselling provided for people with type 2 diabetes mellitus in primary healthcare in North Karelia, Finland: a register-based evaluation study
por: Martiskainen, Tuula Marketta, et al.
Publicado: (2022)

Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study (§)
por: Préau, Yannis, et al.
Publicado: (2021)

Evaluation of Accuracy and Performance of isCGM Sensors during Experimentally Induced Glucose Excursions. Comment on Moser et al. Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis. Biosensors 2021, 11, 22
por: Jessen, Wiebke, et al.
Publicado: (2022)

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population
por: Jalkanen, Kari, et al.
Publicado: (2019)

Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

Relationship between CGM-derived nocturnal hypoglycemia and subjective sleep quality in people with type 1 diabetes
por: Gardner, Daphne, et al.
Publicado: (2023)

Hypoglycemia event prediction from CGM using ensemble learning
por: Fleischer, Jesper, et al.
Publicado: (2022)

Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk
por: Martikainen, Janne, et al.
Publicado: (2022)

PSUN262 A Case of Hypoglycemia and Diabetic Ketoacidosis in an Adult with Down Syndrome
por: Lung, John, et al.
Publicado: (2022)

Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset
por: Worth, Chris, et al.
Publicado: (2022)

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
por: Reddy, Monika, et al.
Publicado: (2018)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

Electronic Health Records as Valuable Data Sources in the Health Care Quality Improvement Process
por: Wikström, Katja, et al.
Publicado: (2019)

Digitally Supported Lifestyle Intervention to Prevent Type 2 Diabetes Through Healthy Habits: Secondary Analysis of Long-Term User Engagement Trajectories in a Randomized Controlled Trial
por: Lavikainen, Piia, et al.
Publicado: (2022)

Erratum. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care 2020;43:2349–2354
por: Toschi, Elena, et al.
Publicado: (2021)

Encephalopathy, Hypoglycemia, and Flailing Extremities: A Case of Bilateral Chorea–Ballism Associated with Diabetic Ketoacidosis
por: Guerrero, Waldo R., et al.
Publicado: (2012)

Agreement between physician- and patient-reported Canadian cardiovascular society scores among patients undergoing elective coronary angiography–The CATS study
por: Lavikainen, Piia, et al.
Publicado: (2023)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
por: Ni, Kevin, et al.
Publicado: (2023)

Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial
por: Verbeeten, Kate C, et al.
Publicado: (2020)

The diabetic ketoacidosis
por: Cardella, Francesca
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_03clnjdr9sded557cmfotlij4m